Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2013

01-06-2013

Long-term breast cancer survivors’ symptoms and morbidity: differences by sexual orientation?

Authors: Ulrike Boehmer, Mark Glickman, Michael Winter, Melissa A. Clark

Published in: Journal of Cancer Survivorship | Issue 2/2013

Login to get access

Abstract

Purpose

Because little is known about morbidity and symptoms among sexual minority women with breast cancer, that is, lesbian or bisexual-identified women, and women with a preference for a woman partner, we examined differences by sexual orientation in long-term survivors’ symptoms and morbidity, considering arm morbidity, systemic therapy side effects, hypertension, and number of comorbidities.

Methods

From a state cancer registry, we recruited 257 heterosexual and 69 sexual minority women (SMW) with a diagnosis of primary, nonmetastatic breast cancer. To increase the number of SMW, we used convenience recruitment methods and obtained an additional 112 SMW who fit the same eligibility criteria as the registry-derived sample. Using a telephone survey, we collected demographic and self-reported data on arm morbidity and systematic therapy side effects, using the European Organization for Research and Treatment of Cancer Quality of Life scale, QLQ-BR23 and a comorbidity measure developed for breast cancer survivors.

Results

Sexual orientation was more strongly associated with arm morbidity and systemic side effects than with high blood pressure and comorbidities. Sexual orientation related indirectly to systemic side effects and arm morbidity through cancer treatments and some demographic factors.

Conclusions

Our finding that SMW respond more negatively to certain cancer treatments compared to heterosexual women suggests an opportunity to intervene with education and support for SMW breast cancer survivors for whom these life-saving treatments are necessary.

Implications for Cancer Survivors

Because breast cancer survivors are at risk for multiple severe and persistent symptoms, assessing such symptoms is an important aspect of survivorship care. Cultural differences in perception of symptoms, communication issues, cultural barriers to reporting of symptoms, and different cultural norms about expressing pain or impairments have been established by studies. Knowledge about differences in impairment and symptoms by sexual orientation will help providers’ efforts to provide high quality care to breast cancer survivors and may enhance cancer survivorship.
Literature
1.
go back to reference Centers for Disease Control and Prevention. Cancer survivors United States, 2007. MMWR Morb Mortal Wkly Rep. 2011;60:269–72. Centers for Disease Control and Prevention. Cancer survivors United States, 2007. MMWR Morb Mortal Wkly Rep. 2011;60:269–72.
3.
go back to reference Schultz PN, Beck ML, Stava C, Vassilopoulou-Sellin R. Health profiles in 5836 long-term cancer survivors. Int J Cancer. 2003;104:488–95.PubMedCrossRef Schultz PN, Beck ML, Stava C, Vassilopoulou-Sellin R. Health profiles in 5836 long-term cancer survivors. Int J Cancer. 2003;104:488–95.PubMedCrossRef
4.
go back to reference Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112:2577–92.PubMedCrossRef Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112:2577–92.PubMedCrossRef
5.
go back to reference Schmitz KH, Speck RM, Rye SA, DiSipio T, Hayes SC. Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the Pulling Through Study. Cancer. 2012;118:2217–25.PubMedCrossRef Schmitz KH, Speck RM, Rye SA, DiSipio T, Hayes SC. Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the Pulling Through Study. Cancer. 2012;118:2217–25.PubMedCrossRef
6.
go back to reference Shah C, Vicini FA. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. Int J Radiat Oncol Biol Phys. 2011;81:907–14 Shah C, Vicini FA. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. Int J Radiat Oncol Biol Phys. 2011;81:907–14
7.
go back to reference Thomas-MacLean RL, Hack T, Kwan W, Towers A, Miedema B, Tilley A. Arm morbidity and disability after breast cancer: new directions for care. Oncol Nurs Forum. 2008;35:65–71.PubMedCrossRef Thomas-MacLean RL, Hack T, Kwan W, Towers A, Miedema B, Tilley A. Arm morbidity and disability after breast cancer: new directions for care. Oncol Nurs Forum. 2008;35:65–71.PubMedCrossRef
8.
go back to reference Rietman JS, Dijkstra PU, Hoekstra HJ, Eisma WH, Szabo BG, Groothoff JW, et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol. 2003;29:229–38.PubMedCrossRef Rietman JS, Dijkstra PU, Hoekstra HJ, Eisma WH, Szabo BG, Groothoff JW, et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol. 2003;29:229–38.PubMedCrossRef
9.
go back to reference Gartner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302:1985–92.PubMedCrossRef Gartner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302:1985–92.PubMedCrossRef
11.
go back to reference Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst. 2001;93:96–111.PubMedCrossRef Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst. 2001;93:96–111.PubMedCrossRef
12.
go back to reference Harris EE, Correa C, Hwang WT, Liao J, Litt HI, Ferrari VA, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol. 2006;24:4100–6.PubMedCrossRef Harris EE, Correa C, Hwang WT, Liao J, Litt HI, Ferrari VA, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol. 2006;24:4100–6.PubMedCrossRef
13.
go back to reference Harris EE. Cardiac mortality and morbidity after breast cancer treatment. Cancer Control. 2008;15:120–9.PubMed Harris EE. Cardiac mortality and morbidity after breast cancer treatment. Cancer Control. 2008;15:120–9.PubMed
14.
go back to reference Towns K, Bedard PL, Verma S. Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer. Curr Oncol. 2008;15:S16–29.PubMedCrossRef Towns K, Bedard PL, Verma S. Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer. Curr Oncol. 2008;15:S16–29.PubMedCrossRef
15.
go back to reference Gandhi S, Verma S. Aromatase inhibitors and cardiac toxicity: getting to the heart of the matter. Breast Cancer Res Treat. 2007;106:1–9.PubMedCrossRef Gandhi S, Verma S. Aromatase inhibitors and cardiac toxicity: getting to the heart of the matter. Breast Cancer Res Treat. 2007;106:1–9.PubMedCrossRef
16.
go back to reference Hayes S, Battistutta D, Newman B. Objective and subjective upper body function six months following diagnosis of breast cancer. Breast Cancer Res Treat. 2005;94:1–10.PubMedCrossRef Hayes S, Battistutta D, Newman B. Objective and subjective upper body function six months following diagnosis of breast cancer. Breast Cancer Res Treat. 2005;94:1–10.PubMedCrossRef
17.
go back to reference Peuckmann V, Ekholm O, Rasmussen NK, Groenvold M, Christiansen P, Moller S, et al. Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain. 2009;13:478–85.PubMedCrossRef Peuckmann V, Ekholm O, Rasmussen NK, Groenvold M, Christiansen P, Moller S, et al. Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain. 2009;13:478–85.PubMedCrossRef
18.
go back to reference Giedzinska AS, Meyerowitz BE, Ganz PA, Rowland JH. Health-related quality of life in a multiethnic sample of breast cancer survivors. Ann Behav Med. 2004;28:39–51.PubMedCrossRef Giedzinska AS, Meyerowitz BE, Ganz PA, Rowland JH. Health-related quality of life in a multiethnic sample of breast cancer survivors. Ann Behav Med. 2004;28:39–51.PubMedCrossRef
19.
go back to reference Im EO, Chee W, Guevara E, Liu Y, Lim HJ, Tsai HM, et al. Gender and ethnic differences in cancer pain experience: a multiethnic survey in the United States. Nurs Res. 2007;56:296–306.PubMedCrossRef Im EO, Chee W, Guevara E, Liu Y, Lim HJ, Tsai HM, et al. Gender and ethnic differences in cancer pain experience: a multiethnic survey in the United States. Nurs Res. 2007;56:296–306.PubMedCrossRef
20.
go back to reference Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Pract. 2007;20:434–43.CrossRef Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Pract. 2007;20:434–43.CrossRef
21.
go back to reference Boehmer U, Linde R, Freund KM. Breast reconstruction following mastectomy for breast cancer: the decisions of sexual minority women. Plast Reconstr Surg. 2007;119:464–72.PubMedCrossRef Boehmer U, Linde R, Freund KM. Breast reconstruction following mastectomy for breast cancer: the decisions of sexual minority women. Plast Reconstr Surg. 2007;119:464–72.PubMedCrossRef
22.
go back to reference Dibble SL, Roberts SA. A comparison of breast cancer diagnosis and treatment between lesbian and heterosexual women. J Gay Lesbian Med Assoc. 2002;6:9–17.CrossRef Dibble SL, Roberts SA. A comparison of breast cancer diagnosis and treatment between lesbian and heterosexual women. J Gay Lesbian Med Assoc. 2002;6:9–17.CrossRef
23.
go back to reference Boehmer U, Glickman M, Milton J, Winter M. Health-related quality of life in breast cancer survivors of different sexual orientations. Qual Life Res. 2012;21:225–36.PubMedCrossRef Boehmer U, Glickman M, Milton J, Winter M. Health-related quality of life in breast cancer survivors of different sexual orientations. Qual Life Res. 2012;21:225–36.PubMedCrossRef
24.
go back to reference Boehmer U, Glickman M, Winter M. Anxiety and depression in breast cancer survivors of different sexual orientations. J Consult Clin Psychol. 2012;80:382–95.PubMedCrossRef Boehmer U, Glickman M, Winter M. Anxiety and depression in breast cancer survivors of different sexual orientations. J Consult Clin Psychol. 2012;80:382–95.PubMedCrossRef
25.
go back to reference Boehmer U, Clark M, Glickman M, Timm A, Sullivan M, Bradford J, et al. Using cancer registry data for recruitment of sexual minority women: successes and limitations. J Womens Health. 2010;19:1289–97.CrossRef Boehmer U, Clark M, Glickman M, Timm A, Sullivan M, Bradford J, et al. Using cancer registry data for recruitment of sexual minority women: successes and limitations. J Womens Health. 2010;19:1289–97.CrossRef
26.
go back to reference Boehmer U, Clark MA, Timm A, Sullivan M, Glickman M. Comparing cancer survivors recruited through a cancer registry to convenience methods of recruitment. Women’s Health Issues. 2011;21:345–52.PubMedCrossRef Boehmer U, Clark MA, Timm A, Sullivan M, Glickman M. Comparing cancer survivors recruited through a cancer registry to convenience methods of recruitment. Women’s Health Issues. 2011;21:345–52.PubMedCrossRef
27.
go back to reference Krieger N. Racial and gender discrimination: risk factors for high blood pressure? Soc Sci Med. 1990;30:1273–81.PubMedCrossRef Krieger N. Racial and gender discrimination: risk factors for high blood pressure? Soc Sci Med. 1990;30:1273–81.PubMedCrossRef
28.
go back to reference Stuber J, Galea S, Ahern J, Blaney S, Fuller C. The association between multiple domains of discrimination and self-assessed health: a multilevel analysis of Latinos and blacks in four low-income New York City neighborhoods. Health Serv Res. 2003;38:1735–60.PubMedCrossRef Stuber J, Galea S, Ahern J, Blaney S, Fuller C. The association between multiple domains of discrimination and self-assessed health: a multilevel analysis of Latinos and blacks in four low-income New York City neighborhoods. Health Serv Res. 2003;38:1735–60.PubMedCrossRef
29.
go back to reference Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002;94:39–49.PubMedCrossRef Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002;94:39–49.PubMedCrossRef
30.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.PubMedCrossRef
31.
go back to reference Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. The EORTC QLQ-C30 Scoring Manual, 3rd edn. Brussels: European Organisation for Research and Treatment of Cancer; 2001. Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. The EORTC QLQ-C30 Scoring Manual, 3rd edn. Brussels: European Organisation for Research and Treatment of Cancer; 2001.
32.
33.
go back to reference Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika. 1991;78:691–2.CrossRef Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika. 1991;78:691–2.CrossRef
34.
35.
go back to reference Stout NL, Binkley JM, Schmitz KH, Andrews K, Hayes SC, Campbell KL, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012;118:2191–200.PubMedCrossRef Stout NL, Binkley JM, Schmitz KH, Andrews K, Hayes SC, Campbell KL, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012;118:2191–200.PubMedCrossRef
36.
go back to reference Cochran SD, Mays VM. physical health complaints among lesbians, gay men, and bisexual and homosexually experienced heterosexual individuals: results from the California quality of life survey. Am J Public Health. 2007;97:2048–55.PubMedCrossRef Cochran SD, Mays VM. physical health complaints among lesbians, gay men, and bisexual and homosexually experienced heterosexual individuals: results from the California quality of life survey. Am J Public Health. 2007;97:2048–55.PubMedCrossRef
37.
go back to reference Boehmer U, Mertz M, Timm A, Glickman M, Sullivan M, Potter J. Overweight and obesity in long-term breast cancer survivors: how does sexual orientation impact BMI? Cancer Invest. 2011;29:220–8.PubMedCrossRef Boehmer U, Mertz M, Timm A, Glickman M, Sullivan M, Potter J. Overweight and obesity in long-term breast cancer survivors: how does sexual orientation impact BMI? Cancer Invest. 2011;29:220–8.PubMedCrossRef
38.
go back to reference Silliman RA, Lash TL. Comparison of interview-based and medical-record based indices of comorbidity among breast cancer patients. Med Care. 1999;37:339–49.PubMedCrossRef Silliman RA, Lash TL. Comparison of interview-based and medical-record based indices of comorbidity among breast cancer patients. Med Care. 1999;37:339–49.PubMedCrossRef
Metadata
Title
Long-term breast cancer survivors’ symptoms and morbidity: differences by sexual orientation?
Authors
Ulrike Boehmer
Mark Glickman
Michael Winter
Melissa A. Clark
Publication date
01-06-2013
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2013
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-012-0260-8

Other articles of this Issue 2/2013

Journal of Cancer Survivorship 2/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine